1577. Particle Characterization of Nebulized Liposomal Amphotericin B and Its Use in the Treatment of Murine Pulmonary Aspergillosis

BACKGROUND: Immunocompromised patients are very susceptible to pulmonary aspergillosis causing 50% mortality with present treatments, indicating a need for improved therapy. To address this, we standardized a nebulization method for effectively delivering liposomal amphotericin B (AmBisome®, AmBi) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dave, Janam J, Sandoval, Adilene, Olson, Jon, Adler-Moore, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809417/
http://dx.doi.org/10.1093/ofid/ofz360.1441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809417/
http://dx.doi.org/10.1093/ofid/ofz360.1441

Ejemplares similares